Thomas R. Staab II
2011
In 2011, Thomas R. Staab II earned a total compensation of $842.2K as Senior Vice President and Chief Financial Officer at BioCryst Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $62,702 |
|---|---|
| Option Awards | $500,000 |
| Salary | $185,000 |
| Stock Awards | $94,500 |
| Total | $842,202 |
Staab received $500K in option awards, accounting for 59% of the total pay in 2011.
Staab also received $62.7K in non-equity incentive plan, $185K in salary and $94.5K in stock awards.
Rankings
In 2011, Thomas R. Staab II's compensation ranked 6,279th out of 10,747 executives tracked by ExecPay. In other words, Staab earned more than 41.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,279 out of 10,747 | 42nd |
Division Manufacturing | 2,270 out of 3,960 | 43rd |
Major group Chemicals And Allied Products | 516 out of 1,033 | 50th |
Industry group Drugs | 338 out of 781 | 57th |
Industry Biological Products, Except Diagnostic Substances | 52 out of 157 | 67th |
Source: SEC filing on March 21, 2014.
Staab's colleagues
We found five more compensation records of executives who worked with Thomas R. Staab II at BioCryst Pharmaceuticals in 2011.
2011
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2011
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2011
Yarlagadda Babu
BioCryst Pharmaceuticals
Senior Vice President of Drug Discovery
2011
David McCullough
BioCryst Pharmaceuticals
Vice President, Strategic Planning, Commercialization and Corporate Development
2011
Stuart Grant
BioCryst Pharmaceuticals